{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T18:57:42Z","timestamp":1781377062182,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,9,16]],"date-time":"2005-09-16T00:00:00Z","timestamp":1126828800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Regular use of beta-agonists leads to tolerance to their bronchodilator effects. This can be demonstrated by measuring the response to beta-agonist following bronchoconstriction using methacholine. However most studies have demonstrated tolerance after a period of beta-agonist withdrawal, which is not typical of their use in clinical practice. This study assessed tolerance to the bronchodilator action of salbutamol during ongoing treatment with long-acting beta-agonist.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Random-order, double-blind, placebo-controlled, crossover trial. After 1 week without beta-agonists, 13 asthmatic subjects inhaled formoterol 12 \u03bcg twice daily or matching placebo for 1 week. Eight hours after the first and last doses subjects inhaled methacholine to produce a 20% fall in FEV<jats:sub>1<\/jats:sub>. Salbutamol 100, 200 and 400 \u03bcg (cumulative dose) was then given at 5-minute intervals and FEV<jats:sub>1<\/jats:sub> was measured 5 minutes after each dose. After a 1 week washout subjects crossed over to the other treatment. Unscheduled use of beta-agonists was not allowed during the study. The main outcome variable was the area under the salbutamol response curve.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The analysis showed a significant time by treatment interaction indicating that the response to salbutamol fell during formoterol therapy compared to placebo. After 1 week of formoterol the area under the salbutamol response curve was 48% (95% confidence interval 28 to 68%) lower than placebo. This reduction in response remained significant when the analyses were adjusted for changes in the pre-challenge FEV<jats:sub>1<\/jats:sub> and dose of methacholine given (p = 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The bronchodilator response to salbutamol is significantly reduced in patients taking formoterol. Clinically relevant tolerance to rescue beta-agonist treatment is likely to occur in patients treated with long-acting beta-agonists.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1465-9921-6-107","type":"journal-article","created":{"date-parts":[[2005,9,17]],"date-time":"2005-09-17T06:14:02Z","timestamp":1126937642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial"],"prefix":"10.1186","volume":"6","author":[{"given":"Sarah","family":"Haney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Hancox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,16]]},"reference":[{"issue":"suppl 1","key":"345_CR1_345","first-page":"1","volume":"58","author":"British Thoracic society","year":"2003","unstructured":"British Thoracic society: British guideline on the management of asthma.\nThorax 2003,58(suppl 1):1\u201383.","journal-title":"Thorax"},{"key":"345_CR2_345","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJM199210223271703","volume":"327","author":"D Cheung","year":"1992","unstructured":"Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ: Long-term effects of a long-acting \u03b2\n\n                    2\n                  \n-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.\nN Engl J Med 1992, 327:1198\u20131203.","journal-title":"N Engl J Med"},{"key":"345_CR3_345","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1164\/ajrccm.152.4.7551366","volume":"152","author":"DH Yates","year":"1995","unstructured":"Yates DH, Sussman HS, Shaw MJ, Barnes PJ, Chung KF: Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.\nAm J Respir Crit Care Med 1995, 152:1170\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"345_CR4_345","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9343(94)90045-0","volume":"97","author":"DM Newnham","year":"1994","unstructured":"Newnham DM, McDevitt DG, Lipworth BJ: Bronchodilator subsensitivity after chronic dosing with eformeterol in patients with asthma.\nAm J Med 1994, 97:29\u201337.","journal-title":"Am J Med"},{"key":"345_CR5_345","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0091-6749(98)70245-3","volume":"101","author":"I Aziz","year":"1998","unstructured":"Aziz I, Hall IP, McFarlane LC, Lipworth BJ: \u03b2\n\n                    2\n                  \n-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.\nJ Allergy Clin Immunol 1998, 101:337\u201341.","journal-title":"J Allergy Clin Immunol"},{"key":"345_CR6_345","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0272-5231(05)70273-2","volume":"21","author":"T Horiuchi","year":"2000","unstructured":"Horiuchi T, Castro M: The pathobiologic implications for treatment. Old and new strategies in the treatment of chronic asthma.\nClin Chest Med 2000, 21:381\u201395.","journal-title":"Clin Chest Med"},{"key":"345_CR7_345","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1034\/j.1399-3003.1999.14b08.x","volume":"14","author":"RJ Hancox","year":"1999","unstructured":"Hancox RJ, Aldridge RE, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Town GI, Taylor DR: Tolerance to beta-agonists during acute bronchoconstriction.\nEur Respir J 1999, 14:283\u20137.","journal-title":"Eur Respir J"},{"key":"345_CR8_345","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1183\/09031936.01.17303680","volume":"17","author":"SL Jones","year":"2001","unstructured":"Jones SL, Cowan JO, Flannery EM, Hancox RJ, Herbison GP, Taylor DR: Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.\nEur Respir J 2001, 17:368\u201373.","journal-title":"Eur Respir J"},{"key":"345_CR9_345","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/thorax.56.7.529","volume":"56","author":"HJ Van der Woude","year":"2001","unstructured":"Van der Woude HJ, Winter TH, Aalbers R: Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate bronchoconstriction during high dose treatment with long acting \u03b2\n\n                    2\n                  \nagonists.\nThorax 2001, 56:529\u2013535.","journal-title":"Thorax"},{"key":"345_CR10_345","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.rmed.2004.05.008","volume":"98","author":"WW Storms","year":"2004","unstructured":"Storms WW, Chervinsky P, Ghannam A, Bird S, Hustad CM, Edelman JM: A comparison of the effects of oral montelukast and inhaled salmeterol on the response to rescue bronchodilation after challenge.\nRespir Med 2004, 98:1051\u201362.","journal-title":"Respir Med"},{"key":"345_CR11_345","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1183\/09031936.03.00067503","volume":"21","author":"JM Wraight","year":"2003","unstructured":"Wraight JM, Hancox RJ, Herbison GP, Cowan JO, Flannery EM, Taylor DR: Bronchodilator tolerance: the impact of increasing bronchoconstriction.\nEur Respir J 2003, 21:810\u20135.","journal-title":"Eur Respir J"},{"key":"345_CR12_345","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1436","volume":"147","author":"KF Rabe","year":"1993","unstructured":"Rabe KF, Jorres R, Nowak D, Behr N, Magnussen H: Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.\nAm Rev Respir Dis 1993, 147:1436\u201341.","journal-title":"Am Rev Respir Dis"},{"key":"345_CR13_345","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/thx.38.10.760","volume":"38","author":"K Yan","year":"1983","unstructured":"Yan K, Salome C, Woolcock AJ: Rapid method for measurement of bronchial responsiveness.\nThorax 1983, 38:760\u20135.","journal-title":"Thorax"},{"key":"345_CR14_345","doi-asserted-by":"crossref","first-page":"19928","DOI":"10.1016\/S0021-9258(19)47200-1","volume":"264","author":"JR Hadcock","year":"1989","unstructured":"Hadcock JR, Wang H, Malbon CC: Agonist-induced destabilization of \u03b2-adrenergic receptor mRNA.\nJ Biol Chem 1989, 264:19928\u201319934.","journal-title":"J Biol Chem"},{"key":"345_CR15_345","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/thx.2003.019059","volume":"59","author":"DKC Lee","year":"2004","unstructured":"Lee DKC, Jackson CM, Bates CE, Lipworth BJ: Cross tolerance to salbutamol occurs independently of \u03b2\n\n                    2\n                  \nadrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.\nThorax 2004, 59:662\u20137.","journal-title":"Thorax"},{"key":"345_CR16_345","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.rmed.2004.10.014","volume":"99","author":"S Haney","year":"2005","unstructured":"Haney S, Hancox RJ: Rapid onset of tolerance to beta-agonist bronchodilation.\nRespir Med 2005, 99:566\u2013571.","journal-title":"Respir Med"},{"key":"345_CR17_345","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0140-6736(95)91589-3","volume":"346","author":"N Barnes","year":"1995","unstructured":"Barnes N: Bronchodilator subsensitivity to salbutamol after salmeterol.\nLancet 1995, 346:968.","journal-title":"Lancet"},{"key":"345_CR18_345","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7326\/0003-4819-140-10-200405180-00018","volume":"140","author":"SR Salpeter","year":"2004","unstructured":"Salpeter SR, Ormiston TM, Salpeter EE: Meta-analysis: respiratory tolerance to regular \u03b2\n\n                    2\n                  \n-agonist use in patients with asthma.\nAnn Intern Med 2004, 140:802\u2013813.","journal-title":"Ann Intern Med"},{"key":"345_CR19_345","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1136\/thx.51.10.1051","volume":"51","author":"DW Cockcroft","year":"1996","unstructured":"Cockcroft DW, Swystun VA: Functional antagonism: tolerance produced by inhaled beta\n\n                    2\n                  \nagonists.\nThorax 1996, 51:1051\u20131056.","journal-title":"Thorax"},{"key":"345_CR20_345","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jaci.2004.03.046","volume":"113","author":"L Hendeles","year":"2004","unstructured":"Hendeles L, Beaty R, Ahrens R, Stevens G, Harman EM: Response to inhaled albuterol during nocturnal asthma.\nJ Allergy Clin Immunol 2004, 113:1058\u201362.","journal-title":"J Allergy Clin Immunol"},{"key":"345_CR21_345","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1046\/j.1365-2125.2003.01887.x","volume":"56","author":"DKC Lee","year":"2003","unstructured":"Lee DKC, Jackson CM, Currie GP, Cockburn WJ, Lipworth BJ: Comparison of combination inhalers vs corticosteroids alone in moderate persistent asthma.\nBr J Clin Pharmacol 2003, 56:494\u2013500.","journal-title":"Br J Clin Pharmacol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-6-107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-6-107\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-6-107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-6-107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T09:49:59Z","timestamp":1630489799000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-6-107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,16]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["345"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-6-107","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,16]]},"assertion":[{"value":"15 April 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"107"}}